Folic acid conjugated magnetic drug delivery system for controlled release of doxorubicin

  • Nidhi Andhariya
  • Ramesh Upadhyay
  • Rasbindu Mehta
  • Bhupendra Chudasama
Research Paper


Targeting tumors by means of their vascular endothelium is a promising strategy, which utilizes targets that are easily accessible, stable, and do not develop resistance against therapeutic agents. Folate receptor is a highly specific tumor marker, frequently over expressed in cancer tumors. In the present study, an active drug delivery system, which can effectively target cancer cells by means of folate receptor-mediated endocytosis, have ability to escape from opsonization and capability of magnetic targeting to withstand the drag force of the body fluid have been designed and synthesized. The core of the drug delivery system is of mono-domain magnetic particles of magnetite. Magnetite nanoparticles are shielded with PEG, which prevents their phagocytosis by reticuloendothelial system. These PEG shielded magnetite nanoparticles are further decorated with an antitumor receptor—folic acid and loaded with an antineoplastic agent doxorubicin. An in vitro drug loading and release kinetics study reveals that the drug delivery system can take 52 % of drug load and can release doxorubicin over a sustained period of 7 days. The control and sustained release over a period of several days may find its practical utilities in chemotherapy where frequent dosing is not possible.


Magnetic drug targeting Active delivery Doxorubicin Folate receptor Magnetite 



This work was financially supported by the Department of Science & Technology, New Delhi, under its fast track scheme SR/FTP/PS-109/2010, University Grants Commission, New Delhi under the DS Kothari postdoctoral fellowship awarded to Dr. N. Andhariya (F.4-2/2006(BSR)/13-467/2011(BSR) and Thapar University, Patiala.


  1. Barrera C, Herrera A, Zayas Y, Rinaldi C (2009) Surface modification of magnetite nanoparticles for biomedical applications. J Magn Magn Mater 321:1397–1399CrossRefGoogle Scholar
  2. Brannon-Peppas L, Blanchette J (2004) Nanoparticles and targeted systems for cancer therapy. Adv Drug Del Rev 56:1649–1659CrossRefGoogle Scholar
  3. Caliceti P, Salmaso S, Semenzato A, Carofiglio T, Fornasier R, Fermeqlia M, Ferrone M, Pricl S (2003) Synthesis and physicochemical characterization of folate: cyclodextrin bioconjugate for active drug delivery. Bioconjugate Chem 14:899–908CrossRefGoogle Scholar
  4. Cascante M, Centelles J, Veech R, Lee W, Boros L (2000) Role of thiamin (Vitamin B1) and transketolase in tumor cell proliferation. Nutr Cancer 36:150–154CrossRefGoogle Scholar
  5. Dreborg S, Akerblom E (1990) Immunotherapy with monomethoxypolyethelene glycol modified allergens. Crit Rev Ther Drug Carrier Sys 63:15–365Google Scholar
  6. Fornari F, Randolph J, Yalowich J, Ritke M, Gewirtz D (1994) Interference by doxorubicin with DNA unwinding in MCF-7 breast tumor cells. Mol Pharmacol 45:649–656Google Scholar
  7. Gupta A, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021CrossRefGoogle Scholar
  8. Harris J (1985) Laboratory synthesis of polyethelene glycol derivatives. J Macromol Sci, Rev Macromol Chem Phys C25:325–373CrossRefGoogle Scholar
  9. Kaul G, Amiji M (2002) Long-circulating poly (ethylene glycol)-modified gelatin nanoparticles for intracellular delivery. Pharm Res 19:1061–1067CrossRefGoogle Scholar
  10. Kiessling L, Gestwicki J, Strong L (2000) Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr Opin Chem Biol 4:696–703CrossRefGoogle Scholar
  11. Koda J, Venook A, Walser E, Goodwin S (2002) Phase I/II trial of hepatic intraarterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocarcinoma. Eur J Cancer 38:S18Google Scholar
  12. Komaki R, Putnam J, Cox J (1997) Thymic neoplasms. Curr Opin Oncol 9:156–160CrossRefGoogle Scholar
  13. Lee K (2005) Stability of Ionic complexes prepared from plasmid DNA and self-aggregated chitosan nanoparticles. Macromol Res 13:542–544CrossRefGoogle Scholar
  14. Li Y, Afzaal M, Brien P (2006) The synthesis of ammine-capped magnetic (Fe, Mn, Co., Ni) oxide nanocrystals and their surface modification for aquous dispersibility. J Mater Chem 16:2175–2180CrossRefGoogle Scholar
  15. Lin C, Chiang RJ, Sung T (2006) Magnetic nanoproperties of monodispersed iron oxide nanoparticles. J App Phys 99: 08N710Google Scholar
  16. Lopez-Quintela M, Rivas J (1993) Chemical reactions in microemulsions: a powerful method to obtain ultrafine particles. J Coll Interface Sci 158:446–451CrossRefGoogle Scholar
  17. Luangtana-anan M, Nunthanid J, Limmatvapirat S (2010) Effect of molecular weight and concentration of polyethylene glycol on physicochemical properties and stability of shellac film. J Agric Food Chem 58:12934–12940CrossRefGoogle Scholar
  18. Lübbe AS, Bergemann C, Huhnt W, Fricke T, Riess H, Brock JW, Huhn D (1996) Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res 56:4694–4701Google Scholar
  19. Lübbe A, Alexiou C, Bergmann C (2001) Clinical applications of magnetic drug targeting. J Surg Res 95:200–206CrossRefGoogle Scholar
  20. Ma M, Zhang Y, Yu W, Shen H, Zhang H, Gu N (2003) Preparation and characterization of magnetite nanoparticles coated by amino silane. J Colloids surf A: 212–219Google Scholar
  21. Maed H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65:271–284CrossRefGoogle Scholar
  22. Mohapatra S, Mallick S, Maiti T, Ghosh S, Pramanik P (2007) Synthesis of highly stable folic acid conjugate magnetite nanoparticles for targeting cancer cells. Nanotechnology 18:385102CrossRefGoogle Scholar
  23. Pankhurst Q, Connolly J, Jones S, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D 36:R167–R181CrossRefGoogle Scholar
  24. Park J, An K, Hwang Y, Park J, Noh H, Kim J, Park J, Hwang N, Hyeon T (2004) Ultra-large-scale syntheses of monodisperse nanocrystals. Nature Mater 3:891–895CrossRefGoogle Scholar
  25. Plank C (2009) Nanomedicine: silence the target. Nat Nanotechnol 4:544–545CrossRefGoogle Scholar
  26. Prozorov T, Prozorov R, Koltypin Yu, Felner I, Gedanken A (1998) Sonochemistry under an applied magnertic field: determining the shape of a magnetic particle. J Phys Chem B 102:10165–10168CrossRefGoogle Scholar
  27. Reddy J, Allagadda V, Leamon C (2005) Targeting therapeutics and imaging agents to folate receptor positive tumors. Curr Pharm Biotechnol 6:131–150CrossRefGoogle Scholar
  28. Sahoo S, Labhasetwar V (2003) Nanotech approaches to drug delivery and imaging. Drug Discov Today 8:1112–1120CrossRefGoogle Scholar
  29. Sugimoto T, Matijevic E (1980) Formation of uniform spherical magnetite particles by crystalization from ferrus hydroxyde gels. J Coll Interface Sci 74:227–243CrossRefGoogle Scholar
  30. Sun S, Zeng H (2002) Size controlled synthesis of magnetite nanoparticles. J Am Chem Soc 124:8204–8205CrossRefGoogle Scholar
  31. Sun S, Zeng H, Robinson D, Raoux S, Rice P, Wang S, Li G (2004) Monodispersed MFe2O4 (M = Fe, Co., Mn)nanoparticles. J Am Chem Soc 126:273–279CrossRefGoogle Scholar
  32. Sun C, Sze R, Zhang M (2006) Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MIR. J Biomed Mater Res, Part A 78A:550–557CrossRefGoogle Scholar
  33. Takakura Y, Maruyama K, Yokoyama M (1999) Passive targeting of drugs. Drug Deliv Syst 14:425–426CrossRefGoogle Scholar
  34. Tang Z, Sorensen C, Klabunde K, Hadjipanayiss G (1991) Preparation of manganese ferrite fine particles from aqueous solution. J Coll Interface Sci 146:38–52CrossRefGoogle Scholar
  35. Wilson M, Kerlan R, Fidleman N (2004) Hepatocellular carncinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite- initial experience with 4 patients. Radiology 230:287–293CrossRefGoogle Scholar
  36. Xie J, Peng S, Brower N, Pourmand N, Wang S, Sun S (2006) One-pot synthesis of monodisperse iron oxide nanoparticles for potential biomedical applications. Pure Appl Chem 78:1003–1014CrossRefGoogle Scholar
  37. Xu Q, Xubu JinC (2005) Self-aggregates of cholic acid hydrazide-dextran conjugates as drug carriers. J Appl Polymer Sci 95:487–493CrossRefGoogle Scholar
  38. Ye X, Daraio C, Wang C, Talbot J, Jin S (2006) Room temperature solvent free synthesis of monodisperse magnetite nanocrystals. J Nanosci Nanotechnol 6:852–856CrossRefGoogle Scholar
  39. Yokoyama M, Okano T (1996) Targetable drug carriers: present status and a future perspective. Adv Drug Deliv Rev 21:77–80CrossRefGoogle Scholar
  40. Zhang J, Misra R (2007) Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: core-shell nanoparticles carriers and drug release response. Acta Biomater 3:838–850CrossRefGoogle Scholar
  41. Zhang J, Srivastava R, Misra R (2007) Core-shell magnetite nanoparticles surface encapsulated with smart stimuli-responsive polymer: synthesis, characterization, and LCST of viable drug- targeting delivery systems. Langmuir 23:6342–6351CrossRefGoogle Scholar
  42. Zhang J, Rana S, Srivastava R, Misra R (2008) On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol functionalized magnetic nanoparticles. Acta Biomater 4:40–48CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  1. 1.School of Physics and Materials ScienceThapar UniversityPatialaIndia
  2. 2.P.D. Patel Institute of Applied SciencesCharotar University of Science and TechnologyChangaIndia
  3. 3.Department of PhysicsMaharaja Krishnakumarsinhji Bhavnagar UniversityBhavnagarIndia

Personalised recommendations